CINCINNATI, Aug. 23 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the appointment of Jeffrey M. Zucker as Senior Director and Global Head, Patient Recruitment. Zucker will provide global leadership for the development and implementation of innovative strategies to accelerate patient recruitment, improve retention and support the timely and efficient delivery of Phase I-IV clinical development programs for the Company's biopharmaceutical customers. He brings nearly 15 years of clinical development and management experience to Kendle.
"Patient recruitment is at the core of the clinical development process," said Stephen Cutler, PhD, Senior Vice President and Chief Operating Officer. "Finding the right patients for the right studies and keeping them engaged throughout is essential to producing sound clinical research. Jeff's extensive management experience across many facets of the biopharmaceutical industry will be a great asset for our customers and we are pleased to welcome him to Kendle."
Zucker brings extensive experience from across the biopharmaceutical industry, including management positions focused on site selection and patient recruitment. In his most recent position, he led global trial optimization efforts for Merck & Co. He also has served as Director of Inpatient Operations at CRI Worldwide and as founder and President of Applied Research Trials, a biopharmaceutical consulting firm focused on improving clinical research trials and processes. Zucker has held leadership positions for Eli Lilly, Princeton Biomedical Research and multiple clinical investigative sites. He holds a Master of Science in Group Process and Group Psychotherapy from Hahnemann University in Philadelphia and a Bachelor of Science in psychology from Pennsylvania State
|SOURCE Kendle International Inc.|
Copyright©2010 PR Newswire.
All rights reserved